10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016).

Syndikus, Isabel, Griffin, Clare, Philipps, Lara, Tree, Alison, Khoo, Vincent, Birtle, Alison Jane, Choudhury, Ananya, Ferguson, Catherine, O'Sullivan, Joe M., Panades, Miguel, Rimmer, Yvonne L., Scrase, Christopher D., Staffurth, John ORCID: https://orcid.org/0000-0002-7834-3172, Cruickshank, Clare, Hassan, Shama, Pugh, Julia, Dearnaley, David P. and Hall, Emma 2023. 10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016). Presented at: 2023 ASCO Genitourinary Cancers Symposium, San Francisco, 16-18 February 2023. Journal of Clinical Oncology. , vol.41 (S6) American Society of Clinical Oncology, p. 304. 10.1200/JCO.2023.41.6_suppl.304

Full text not available from this repository.

Item Type:	Conference or Workshop Item (UNSPECIFIED)
Date Type:	Published Online
Status:	Published
Schools:	Schools > Medicine
Publisher:	American Society of Clinical Oncology
ISSN:	0732-183X
Last Modified:	13 Apr 2023 15:30
URI:	https://orca.cardiff.ac.uk/id/eprint/158568

Actions (repository staff only)

Edit Item